[ad_1]
Dr. Anwar Al-Masoud, a gastrointestinal tumor consultant and badistant professor at the Cancer Center at the University of Kansas, United States, was invited by the Medical Research Forum of the Gulf Arab College of Medicine to give a lecture on the latest developments in immunotherapy for advanced gastric and oesophageal tumors.
The conference focused on the latest US and international studies on the possibilities of these promising treatments, which rely on immune system stimulation and the search for antitumor antibodies that destroy cancer cells throughout the body. said that immunotherapy had led to significant advances over the past decade, cancer has achieved excellent results that conventional therapies such as chemotherapy and radiation can not achieve.
During her presentation, she explained that anti-cancer immunotherapy is one of the newest cancer treatment methods. It is available in a few countries such as the United States and Britain because of the recent treatment methods and the shortage of specialized oncologists with the experience and knowledge in these advanced treatments. Gastrointestinal, emphasizing that the selection of appropriate cases of immunotherapy is done by accurate tests of the genetic code of tumors DNA Ensure that genetic mutations are accurately determined by laboratory and genetic tests on tumor samples. The attending physician noted that immunotherapy and genetic testing of tumors had become an essential step in the diagnosis and treatment of tumors in specialized cancer treatment centers in major US university hospitals, and that strategies in oncology have been substantially updated over the past decade to cope with the momentum and promising successes. Which are confirmed by numerous clinical studies Randomized controlled trials To thousands of cancer patients of all types, which led the American Society of Cancer and the American Society of Blood Diseases to update oncology treatment recommendations to include the latest immunological treatments adopted by the Food and Drug Administration FDA.
It should be noted that the Assistant Doctor graduated from the Faculty of Medicine and Medical Sciences of Gulf Arab University in 2005, and that he specializes in tumors of the digestive system and liver. He also directs several clinical researches in this field in the United States. He has also published several research papers in periodical scientific journals. In many specialized medical conferences, he has scientific interests in the medical research laboratory on cancer cells and medical training where medical school students, medical residents and medical doctors oncology and blood diseases at the Comprehensive Cancer Center University and Kansas in America.
The conference, held at Arab Gulf University, is part of the efforts of the Faculty of Medicine and the Alumni Association to attract distinguished graduates. academics that they support the scientific progress of the university and enrich medical cooperation and continuing education..
Source link
